Variant report
Variant | nsv559151 |
---|---|
Chromosome Location | chr12:62390768-62394361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11832185 | chr12:62390768-62390769 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs546948917 | chr12:62390777-62390778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12819244 | chr12:62390830-62390831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146540260 | chr12:62390859-62390860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192160512 | chr12:62390894-62390895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554629949 | chr12:62390907-62390908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs202078533 | chr12:62390943-62390944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35419865 | chr12:62390948-62390949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72514111 | chr12:62390949-62390950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548448779 | chr12:62390972-62390973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56011904 | chr12:62390974-62390975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34091693 | chr12:62390975-62390976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35284265 | chr12:62390976-62390977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368766501 | chr12:62390978-62390979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570697792 | chr12:62390980-62390981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539091940 | chr12:62390982-62390983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552918493 | chr12:62391006-62391007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572642410 | chr12:62391016-62391017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145403184 | chr12:62391064-62391065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555000405 | chr12:62391082-62391083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148957697 | chr12:62391087-62391088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544758731 | chr12:62391139-62391140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564650125 | chr12:62391152-62391153 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143758816 | chr12:62391160-62391161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs386763594 | chr12:62391166-62391167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12228666 | chr12:62391173-62391174 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs529256229 | chr12:62391200-62391201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79901243 | chr12:62391238-62391239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549507097 | chr12:62391261-62391262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73312225 | chr12:62391262-62391263 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs34004942 | chr12:62391281-62391282 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35735701 | chr12:62391288-62391289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12371873 | chr12:62391298-62391299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185176786 | chr12:62391326-62391327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550729055 | chr12:62391422-62391423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371734484 | chr12:62391428-62391429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148153504 | chr12:62391455-62391456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79977768 | chr12:62391496-62391497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17125609 | chr12:62391552-62391553 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs566136905 | chr12:62391557-62391558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77043770 | chr12:62391588-62391589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35341551 | chr12:62391613-62391614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555061245 | chr12:62391618-62391619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574969314 | chr12:62391622-62391623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10877780 | chr12:62391626-62391627 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs539041819 | chr12:62391635-62391636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558319190 | chr12:62391743-62391744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs578218848 | chr12:62391766-62391767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201733431 | chr12:62391843-62391844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540921303 | chr12:62391864-62391865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Man infertility | 21397064 | CNVD |
Mental retardation | 17220210 | CNVD |
Osteopoikilosis | 17220210 | CNVD |
short stature | 17220210 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Schizophrenia | 21346763 | CNVD |
Breast cancer | 20369283 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:62386400-62392600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr12:62387800-62392600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr12:62390200-62391200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr12:62390600-62391000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr12:62391000-62392600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr12:62391200-62393600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr12:62392400-62393200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr12:62392600-62393000 | Enhancers | Brain Anterior Caudate | brain |
9 | chr12:62392600-62393000 | Enhancers | Duodenum Smooth Muscle | Duodenum |
10 | chr12:62392600-62393200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr12:62392600-62393200 | Enhancers | Brain Hippocampus Middle | brain |
12 | chr12:62392600-62393400 | Enhancers | Adipose Nuclei | Adipose |
13 | chr12:62392600-62393600 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr12:62392600-62394200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
15 | chr12:62393000-62393400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
16 | chr12:62393200-62393600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr12:62393400-62396600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
18 | chr12:62393600-62396600 | Weak transcription | Primary monocytes fromperipheralblood | blood |